Authors:
Narkio-Makela, M
Hellwage, J
Tahkokallio, O
Meri, S
Citation: M. Narkio-makela et al., Complement-regulator factor H and related proteins in otitis media with effusion, CLIN IMMUNO, 100(1), 2001, pp. 118-126
Citation: S. Meri et M. Baumann, Proteomics: posttranslational modifications, immune responses and current analytical tools, BIOMOL ENG, 18(5), 2001, pp. 213-220
Authors:
Ylitalo, K
Pajukanta, P
Meri, S
Cantor, RM
Mero-Matikainen, N
Vakkilainen, J
Nuotio, I
Taskinen, MR
Citation: K. Ylitalo et al., Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia, ART THROM V, 21(5), 2001, pp. 838-843
Authors:
Seppanen, M
Lokki, ML
Timonen, T
Lappalainen, M
Jarva, H
Jarvinen, A
Sarna, S
Valtonen, V
Meri, S
Citation: M. Seppanen et al., Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infections, CLIN INF D, 33(9), 2001, pp. 1604-1607
Authors:
Harjunpaa, A
Wiklund, T
Collan, J
Janes, R
Rosenberg, J
Lee, D
Grillo-Lopez, A
Meri, S
Citation: A. Harjunpaa et al., Complement activation in circulation and central nervous system after Rituximab (Anti-CD20) treatment of B-Cell lymphoma, LEUK LYMPH, 42(4), 2001, pp. 731-738
Authors:
Hiltunen, JO
Laurikainen, A
Vakeva, A
Meri, S
Saarma, M
Citation: Jo. Hiltunen et al., Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion, J PATHOLOGY, 194(2), 2001, pp. 247-253
Citation: Mt. Holmberg et al., Regulation of complement classical pathway by association of C4b-binding protein to the surfaces of SK-OV-3 and caov-3 ovarian adenocarcinoma cells, J IMMUNOL, 167(2), 2001, pp. 935-939
Authors:
Hellwage, J
Meri, T
Heikkila, T
Alitalo, A
Panelius, J
Lahdenne, P
Seppala, IJT
Meri, S
Citation: J. Hellwage et al., The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi, J BIOL CHEM, 276(11), 2001, pp. 8427-8435
Authors:
Rautemaa, R
Rautelin, H
Puolakkainen, P
Kokkola, A
Karkkainen, P
Meri, S
Citation: R. Rautemaa et al., Survival of Helicobacter pylori from complement lysis by binding of GPI-anchored protectin (CD59), GASTROENTY, 120(2), 2001, pp. 470-479
Authors:
Yang, J
Kubera, M
Zelek-Molik, A
Nalepa, I
Hukkanen, V
Lindsberg, PJ
Meri, S
Seljelid, R
Citation: J. Yang et al., Splenectomy and adoptive cell transfer reveal a prominent role for splenicmemory lymphocytes in the development of chronic relapsing experimental autoimmune encephalomyelitis, SC J IMMUN, 52(4), 2000, pp. 356-361
Citation: A. Vakeva et al., Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction, SC J IMMUN, 52(4), 2000, pp. 411-414
Citation: A. Harjunpaa et al., Rituximab (anti-CD20) therapy of B-cell lymphomas: Direct complement killing is superior to cellular effector mechanisms, SC J IMMUN, 51(6), 2000, pp. 634-641
Citation: Lb. Yang et al., Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease, J NEUROSC, 20(20), 2000, pp. 7505-7509
Authors:
Wiberg, ME
Saari, SAM
Westermarck, E
Meri, S
Citation: Me. Wiberg et al., Cellular and humoral immune responses in atrophic lymphocytic pancreatitisin German shepherd dogs and rough-coated collies, VET IMMUNOL, 76(1-2), 2000, pp. 103-115
Citation: T. Meri et al., Resistance of Trichomonas vaginalis to metronidazole: Report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations, J CLIN MICR, 38(2), 2000, pp. 763-767
Citation: M. Narkio-makela et al., Complement C3 cleavage and cytokines interleukin-1 beta and tumor necrosisfactor-alpha in otitis media with effusion, LARYNGOSCOP, 110(10), 2000, pp. 1745-1749
Authors:
Pangburn, MK
Pangburn, KLW
Koistinen, V
Meri, S
Sharma, AK
Citation: Mk. Pangburn et al., Molecular mechanisms of target recognition in an innate immune system: Interactions among factor H, C3b, and target in the alternative pathway of human complement, J IMMUNOL, 164(9), 2000, pp. 4742-4751
Authors:
Junnikkala, S
Jokiranta, TS
Friese, MA
Jarva, H
Zipfel, PF
Meri, S
Citation: S. Junnikkala et al., Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1, J IMMUNOL, 164(11), 2000, pp. 6075-6081
Authors:
Jokiranta, TS
Hellwage, J
Koistinen, V
Zipfel, PF
Meri, S
Citation: Ts. Jokiranta et al., Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J BIOL CHEM, 275(36), 2000, pp. 27657-27662
Authors:
Friese, MA
Hellwage, J
Jokiranta, TS
Meri, S
Muller-Quernheim, HJ
Peter, HH
Eibel, H
Zipfel, PF
Citation: Ma. Friese et al., Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA), CLIN EXP IM, 121(2), 2000, pp. 406-415